Newly funded studies explore how our Perception Box is formed, what causes it to narrow or expand, and whether experiences, including mindfulness, dreams, psychedelics, play, and virtual reality, can help us become more aware of what shapes our experience and…
Key appointment strengthens operational leadership as Psilera prepares its lead neuroplastogen, PSIL-006, for clinical-stage evaluation. TAMPA, Fla., Aug. 27, 2026 /PRNewswire/ -- Psilera Inc. ("Psilera"), a leading biopharmaceutical company pioneering next-g…
NEW YORK — Definium Therapeutics, Inc. (Nasdaq: DFTX) (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, t…
Over the past several months, I’ve been building Ketalux.com, an independent educational platform focused on ketamine therapy, research, safety, treatment options, clinical trials, regulation, providers, and the rapidly evolving ecosystem surrounding ketamine…
What ensued was a wild night of crazed celebrations, alleged drink and drug-fueled debauchery and alleged sexcapades that spiraled into the most sordid sports scandal in a generation.
For those living in the shadow of mental health conditions such as PTSD, anxiety, and depression, finding a way forward can sometimes feel impossible – especially when conventional treatments have offered little succor.
“Our psychedelic-climate leaders are active today, creating change and doing compelling transformational work in this space.”
The post Psychedelics for Climate Action (12,000 cultists) appeared first on Watts Up With That?.
A feasibility trial delivering psilocybin-assisted therapy for treatment-resistant depression within the UK health service reports encouraging adherence and safety — it opens future questions about who is reached, where treatment happens and what standards wi…
Psychedelics are becoming more clinically relevant, and a slew of recent research has explored the effects of psilocybin in ever-greater detail, revealing that it has the ability to imprint lasting, meaningful changes in brain activity. Psilocybin, the psych…
Rogan had called the President's attention to psychedelics by texting him a message with statistics about how ibogaine could help reduce opioid addiction.
Oregon was the first state to establish a legalized and regulated psilocybin industry. Since then, thousands have tried magic mushrooms. Here is the first data from the state's real life experiment.
Psychedelics are inherently chaotic drugs, dissolving the boundary between self and surrounds by sowing discord in the brain.Continue ReadingCategory: Mental Health, Brain Health, Body and Mind, Refractor: Science & HealthTags: Psychedelic Medicine, psilocybi…
The psychedelic psilocybin reorganizes brain activity into structured, context-aligned patterns that integrate internal and external processing, providing a neural basis for the felt continuity between self and world, elucidating how the psychedelic stat…
The University of Miami has given its investigational new drug application of ibogaine, a plant-based psychoactive compound, to the federal government, President Donald Trump said Tuesday.
The post Trump: University of Miami Gives Ibogaine Investigational Dr…
Company says growing federal commitment to ibogaine aligns directly with the pharmaceutical development and manufacturing platform Psyence BioMed has built NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) — Psyence BioMed Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “…
Former Intra-Cellular Therapies, Inc. (“Intra-Cellular”) executives bring complementary experience in organizational scale-up, central nervous system (“CNS”) drug development, regulatory approvals and commercialization Ms. Donohue is the former Chief Human Re…
VANCOUVER, British Columbia, Aug. 14, 2026 (GLOBE NEWSWIRE) — Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the “Company” or “Optimi”), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced that it…
The U.S. Department of Veterans Affairs today announced the launch of a new clinical trial to evaluate the effectiveness and safety of psilocybin to treat major depression in Veterans, including those with concurrent PTSD.The new trial comes after a recent ex…
On The Political Scene Podcast, Trump’s executive order accelerating research into compounds like ibogaine marks a striking turn for a party that was once on the front lines of the war on drugs.
Definium Therapeutics (DFTX) unveiled the second positive Phase 3 study for its LSD-based drug on Thursday, and the biotech stock jumped. Patients with generalized anxiety disorder, or GAD, showed a 5.4-point improvement compared with a placebo on the 56-poin…
Definium Therapeutics unveiled the second of two positive Phase 3 studies for its LSD-based drug. The biotech stock surged on the results.
The post This LSD-Based Drug Just Scored Again. Definium Stock Soars. appeared first on Investor's Business Daily.
Collaboration will leverage Osmind's real-world evidence platform and national clinical network to support Tasman's pivotal Phase 3 ROCKET program, launch readiness, and growth. R-107 is an investigational oral extended-release ketamine product designed for a…
Study met primary and all key secondary efficacy endpoints Participants receiving DT120 ODT achieved a statistically significant reduction in Hamilton Anxiety Rating Scale (HAM-A) score, with a placebo-adjusted change of 5.4 points from baseline at Week 12 (p
In 2026, roughly one in eight American adults is on a GLP-1 like Ozempic, Wegovy, or Mounjaro, more than double the rate of eighteen months earlier. They were originally developed to treat type 2 diabetes; Ozempic won FDA approval for that in 2017, well befor…
For nearly a century, scientists have been baffled by bizarre reports of hallucinations that leave people seeing dozens or even hundreds of tiny human figures.
“We didn’t expect to see this."ScienceAlert stories are written, fact-checked, and edited by humans, never generated by AI. Don't miss a story, subscribe here.
CEO Michael Halstead to participate in a fireside chat on Wednesday, August 12 at 12:00 p.m. EDT NEW YORK and TORONTO, Aug. 10, 2026 (GLOBE NEWSWIRE) — Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP) (the “Company” or “Helus Pharma”), a clinical-stage pharmaceut…
An open library of psychedelic, meditation, dream, and consciousness research. Plain-language summaries with study design and sample size, free to read.
The Department of Veterans Affairs (VA) has launched a new medical trial to determine the effectiveness of using psilocybin to treat depression in veterans.
In April, President Donald Trump issued an executive order to expand access to and trials of psychedel…
MIAMI, Aug. 07, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) today announced that the FDA has completed first-cycle review of the Company’s ANDA for its preservative-free ketamine, with no major deficiencies related to the drug product, i…
How the conservative activist Bryan Hubbard, with help from Rick Perry and Joe Rogan, persuaded Trump and the G.O.P. to embrace ibogaine, a psychedelic drug derived from an African shrub. Michelle Lhooq writes.
As Alaska and the rest of the nation search for innovative solutions to combat rising mental health crises, a Massachusetts law enforcement leader says the key to saving lives lies in transforming how first responders approach human suffering.
Arizona granted Barrow Neurological Institute $5 million for an ibogaine trial in traumatic brain injury. The design, the Schedule I status, and the cardiac risk.
Eli Lilly’s multibillion-dollar acquisition of a company that makes experimental psychedelic therapies marks the largest investment yet by a drugmaker in psychedelic medicine as a treatment for depression. But pharma’s entry into the market raises questions a…
Chiu et al. have developed engineered HTR2A mouse lines enabling in vivo mapping, targeting and modulation of receptor-expressing neurons and validated their utility across biochemical, electrophysiological and behavioral studies of psychedelic mechanisms.
In a publicly funded trial undertaken in the NHS in England, 60 adults with treatment-resistant major depression received psilocybin or placebo alongside standardized psychological support, with psilocybin showing significant improvements in depression sympto…
Netflix billed the January retreat as a "Vulnerability-Trust exercise," held at Sendero Ranch, a company property in Northern California. Kevin Baillie, then head of creative at Netflix's Eyeline Studios, used his turn to disclose that he'd taken supervised k…
The cat is out of the bag with cannabis. Anyone who thinks this goes back in the box is out of their mind — I said it last week, and I’ll say it again: more Americans partake in cannabis now than smoke cigarettes or drink alcohol. Americans like to drink, smo…
Kevin Baillie was VP, Head of Creative/Head of Studio at Eyeline Studios, Netflix’s visual effects division, when he showed up to a company retreat in January 2026. The retreat included a “Vulnerability-Trust exercise” meant to encourage team building. Bailli…
Human Research Ethics Committee (HREC) approval secured for world-first phase 1b/2a 8-indication basket study across in 72-patients of TRP-8803 Study will evaluate TRP-8803 (IV-infused psilocin) across eight major disorders with high unmet treatment needs in …
TAMPA, Fla., Aug. 4, 2026 /PRNewswire/ -- Psilera Inc. ("Psilera"), a leading biopharmaceutical company pioneering next-generation neuroplastogens and psychedelic therapies, today announced its fall conference schedule. Executive and scientific leadership wil…
Ketamine can rapidly relieve severe depression and suicidal thinking when prescribed and monitored. But misuse is rising and can cause addiction and serious medical complications.
Ten combat sports fighters suffering from traumatic brain injuries went to Medellín, Colombia, for eight days of psychedelic neuroplasticity-enhancing treatment. The lessons could benefit all of us.
Founder-backed investment supports accelerated clinical development through a fully funded Phase 1/2 program GREENWICH, Conn., Aug. 3, 2026 /PRNewswire/ -- Ceruvia Lifesciences, a leading neurotransformational biopharmaceutical company, today announced an $8 …
Vancouver, Canada, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation psychedelic, …
Former President of Intra-Cellular Therapies, Inc. was instrumental in building and scaling the company, which was subsequently acquired by Johnson & Johnson Experienced executive with a proven track record of guiding pharmaceutical companies through late-sta…
Early results from a clinical trial at HaEmek Medical Center suggest MDMA-assisted psychotherapy could help combat veterans recover from PTSD, with most participants no longer meeting the criteria for the disorder.
Doctors use ketamine on patients as general anesthesia before surgery. They also prescribe it in low doses for pain management, and more recently, it's been used for treatment-resistant depression where other drugs have failed.